Physician profile
Abigail Joy Soderdahl
NPI 1619775236
$2,274.72
in general payments reported to CMS, 2019-2025
16 companies · $2,275 in 2025
The $2,275 reported for 2025 was more than what 92% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,557 · Travel and Lodging: $682 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,556.80 |
| Travel and Lodging | $681.92 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,092.40 | 2025 | Interstim |
| Teleflex LLC | $238.84 | 2025 | Barrigel |
| Dendreon Pharmaceuticals LLC | $209.09 | 2025 | Provenge |
| Janssen Biotech, INC. | $146.96 | 2025 | Erleada |
| Avation Medical, INC. | $139.93 | 2025 | Vivally System |
| Pfizer INC. | $90.03 | 2025 | |
| Endo USA, INC. | $65.61 | 2025 | Aveed, Xiaflex |
| Novartis Pharmaceuticals Corporation | $57.12 | 2025 | |
| Ferring Pharmaceuticals INC. | $54.49 | 2025 | Adstiladrin |
| Azurity Pharmaceuticals, INC. | $42.37 | 2025 | Azmiro |
| Sumitomo Pharma America, INC. | $37.36 | 2025 | Orgovyx |
| Olympus America INC. | $30.30 | 2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $24.54 | 2025 | |
| Tolmar, INC. | $17.20 | 2025 | Jatenzo, Eligard |
| Accord Healthcare, INC. | $16.08 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $12.40 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Soderdahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.